title: Myelomastocytic leukemia with aberrant CD25 expression: case report and review of the literature.
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Amy
authors.initials: A
authors.lastname: Rich
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Jinlan
authors.initials: J
authors.lastname: Sun
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: Abdulrahman S
authors.initials: AS
authors.lastname: Aldayel
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: C Cameron
authors.initials: CC
authors.lastname: Yin
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: L Jeffrey
authors.initials: LJ
authors.lastname: Medeiros
authors.affiliation: Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: skonople@mdanderson.org.
authors.forename: Sergej
authors.initials: S
authors.lastname: Konoplev
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery; D000951:Antigens, Neoplasm / Q000032:analysis*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D001853:Bone Marrow / Q000473:pathology; D001921:Brain / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000209:etiology; D003561:Cytarabine / Q000008:administration & dosage; D017809:Fatal Outcome; D006801:Humans; D006877:Hydroxamic Acids / Q000008:administration & dosage; D015255:Idarubicin / Q000008:administration & dosage; D053645:Interleukin-2 Receptor alpha Subunit / Q000032:analysis*; D015470:Leukemia, Myeloid, Acute / Q000097:blood / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D017254:Leukemic Infiltration; D008297:Male; D008407:Mast Cells / Q000473:pathology; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D014411:Neoplastic Stem Cells / Q000473:pathology; D009894:Opportunistic Infections / Q000209:etiology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000601:surgery; D000077337:Vorinostat
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D006877:Hydroxamic Acids; C508017:IL2RA protein, human; D053645:Interleukin-2 Receptor alpha Subunit; D003561:Cytarabine; D000077337:Vorinostat; D015255:Idarubicin
keywords: AML; Mast cell differentiation; Mast cell leukemia; Myelomastocytic overlap syndrome; Systemic mastocytosis